AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Apriglim-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Aprica Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Apriglim-M1 Tablet PR

Diabetic patients using GlucoDuo-M1 tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This combination therapy regulates blood glucose in adults. GlucoDuo-M1 should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage, determined by your physician, may be adjusted based on blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation risks elevated glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. Remember, this medication complements a holistic approach encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your physician of any heart history before initiating treatment, as it may be unsuitable. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring, along with blood cell and liver function tests, are recommended by your physician.

Uses of Apriglim-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Apriglim-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Consume Apriglim-M1 Tablet PR with a meal.

Common Side effects of Apriglim-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Apriglim-M1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Apriglim-M1 Tablet PR with a meal.

How Apriglim-M1 Tablet PR works:

Apriglim-M1 PR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Apriglim-M1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Apriglim-M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Apriglim-M1 Tablet PR due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Apriglim-M1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Apriglim-M1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Apriglim-M1 Tablet PR should generally begin at a low dose; however, it's unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Apriglim-M1 Tablet PR :

Should you forget to take your Apriglim-M1 Tablet PR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Apriglim-M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Apriglim-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Apriglim-M1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Apriglim-M1 Tablet PR and seek immediate medical attention.
Apriglim-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Apriglim-M1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Apriglim-M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Apriglim-M1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Apriglim-M1 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Apriglim-M1 Tablet PR
54
MRP 63
13% off